DC-based cancer vaccines

E Gilboa - The Journal of clinical investigation, 2007 - Am Soc Clin Investig
Because of the large preexisting antigenic load and immunosuppressive environment within
a tumor, inducing therapeutically useful antitumor immunity in cancer patients requires the …

Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs

RM Wong, RR Scotland, RL Lau, C Wang… - International …, 2007 - academic.oup.com
Negative co-stimulatory signaling mediated via cell surface programmed death (PD)-1
expression modulates T and B cell activation and is involved in maintaining peripheral …

High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines

Y Zhao, AD Bennett, Z Zheng, QJ Wang… - The Journal of …, 2007 - journals.aai.org
We examined the activity of human T cells engineered to express variants of a single TCR
(1G4) specific for the cancer/testis Ag NY-ESO-1, generated by bacteriophage display with a …

Mobilizing the low-avidity T cell repertoire to kill tumors

RH McMahan, JE Slansky - Seminars in cancer biology, 2007 - Elsevier
Optimally, T cells destroy infected and transformed cells of the host. To be effective the T cell
repertoire must have a sufficiently diverse number of T cell receptors (TCRs) to recognize …

High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection

T Dong, E Moran, N Vinh Chau, C Simmons, K Luhn… - PloS one, 2007 - journals.plos.org
Background Dengue is one of the most important human diseases transmitted by an
arthropod vector and the incidence of dengue virus infection has been increasing–over half …

Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax®

M Mansour, B Pohajdak, WM Kast… - Journal of Translational …, 2007 - Springer
Background Melanoma tumors are known to express antigens that usually induce weak
immune responses of short duration. Expression of both tumor-associated antigens p53 and …

Monoclonal T-cell receptors: new reagents for cancer therapy

HJ Stauss, M Cesco-Gaspere, S Thomas, DP Hart… - Molecular Therapy, 2007 - cell.com
Adoptive transfer of antigen-specific T lymphocytes is an effective form of immunotherapy for
persistent virus infections and cancer. A major limitation of adoptive therapy is the inability to …

[PDF][PDF] Enhancing immune responses for cancer therapy

SA Xue, HJ Stauss - Cell Mol Immunol, 2007 - cmi.ustc.edu.cn
Although the immune system possesses the means to respond to cancer, it often fails to
control the spread of malignancy. Nonetheless, equipping endogenous immunity to release …

Redirecting T lymphocyte specificity by T cell receptor gene transfer–a new era for immunotherapy

B Engels, W Uckert - Molecular aspects of medicine, 2007 - Elsevier
The therapeutic efficacy of adoptively transferred cytotoxic T lymphocytes (CTL) has been
demonstrated in clinical trials for the treatment of chronic myelogenous leukemia …

Cutting edge: CD8+ T cell clones possess the potential to differentiate into both high-and low-avidity effector cells

CJ Kroger, MA Alexander-Miller - The Journal of Immunology, 2007 - journals.aai.org
The property of functional avidity is recognized to be of critical importance in determining
pathogen clearance. An unresolved question with regard to this property is whether distinct …